Cargando…
STAT3 is a master regulator of epithelial identity and KRAS-driven tumorigenesis
A dichotomy exists regarding the role of signal transducer and activator of transcription 3 (STAT3) in cancer. Functional and genetic studies demonstrate either an intrinsic requirement for STAT3 or a suppressive effect on common types of cancer. These contrasting actions of STAT3 imply context depe...
Autores principales: | D'Amico, Stephen, Shi, Jiaqi, Martin, Benjamin L., Crawford, Howard C., Petrenko, Oleksi, Reich, Nancy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120712/ https://www.ncbi.nlm.nih.gov/pubmed/30135074 http://dx.doi.org/10.1101/gad.311852.118 |
Ejemplares similares
-
STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer
por: D’Amico, Stephen, et al.
Publicado: (2023) -
KRAS drives immune evasion in a genetic model of pancreatic cancer
por: Ischenko, Irene, et al.
Publicado: (2021) -
IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3
por: Petrenko, Oleksi, et al.
Publicado: (2021) -
A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells
por: Ischenko, Irene, et al.
Publicado: (2015) -
KRAS-dependent suppression of MYC enhances the sensitivity of cancer cells to cytotoxic agents
por: Ischenko, Irene, et al.
Publicado: (2017)